Assyro AI

FDA PDUFA dates in October 2026

Published PDUFA target action dates for NDAs, BLAs, ANDAs, and INDs scheduled in October 2026, sourced from FDA primary records.

Tracking 4 published FDA PDUFA decisions, including 2 NDAs and 2 BLAs.

FDA PDUFA dates in October 2026: 4 published FDA PDUFA target action dates.
SponsorProductTypeApplicationPDUFA dateStatus
Merck and EisaiWELIREG + LENVIMANDAPENDING-provisional|merckandeisai|welireglenvima|advanceupcoming
Daiichi Sankyo and Merckifinatamab deruxtecanBLAPENDING-provisional|daiichisankyoandmerck|ifinatamabderuupcoming
Opus Genetics and Viatrisphentolamine ophthalmic solution 0.75%NDAPENDING-provisional|opusgeneticsandviatris|phentolamineoupcoming
INOVIO PharmaceuticalsINO-3107BLAPENDING-provisional|inoviopharmaceuticals|ino3107|recurrupcoming

Use the calendar, timeline, status board, or table views above to filter, sort, and inspect source-linked details.

October 2026 FDA PDUFA Calendar: Drug Approval Dates & Deadlines

Track October 2026 FDA PDUFA dates for NDA, BLA, ANDA, and IND decisions. Free drug approval tracker with source-linked deadlines, calendar views, and daily updates.